Document is current
Any future updates will be listed below
-
Authors
Liu, Hongzhong
Yuan, Yuping
Tian, Wei
Luo, Tianhong
Xu, Qian
Zhu, Xiaoyan
Chen, Rui
-
Funding
Funding for this research was provided by:
This study was funded by GenSci.
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 5 June 2025
First Online: 25 July 2025
Declarations
:
: Xiaoyan Zhu, Qian Xu, and Tianhong Luo are employees of GenSci. Hongzhong Liu, Yuping Yuan, Wei Tian, and Rui Chen have nothing to disclose.
: This study was approved by the Ethics Committee at Peking Union Medical College Hospital (approval number HS2019005). The study was conducted in accordance with the local legislation and institutional requirements, and the study was conducted in compliance with the ethical standards established in the 1964 Declaration of Helsinki and its subsequent amendments, with the exception that this trial was retrospectively registered at ClinicalTrials.gov. This trial was prospectively registered on the Chinese Clinical Trial Register (chinadrugtrials.org; registration number CTR20190319) in 2019, prior to first patient enrolment, and subsequently registered on ClinicalTrials.gov in 2020 after study initiation. All participants provided written informed consent before the study.
